Achieve Life Sciences ACHV Contingent consideration fair value adjustments
Contingent consideration fair value adjustments at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's contingent consideration fair value adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's contingent consideration fair value adjustments?
- Achieve Life Sciences (ACHV) reported contingent consideration fair value adjustments of -$285K in Q1 2026.
- How has Achieve Life Sciences's contingent consideration fair value adjustments changed year-over-year?
- Achieve Life Sciences's contingent consideration fair value adjustments decreased by 413.2% year-over-year, from $91K to -$285K.
- What is the long-term trend for Achieve Life Sciences's contingent consideration fair value adjustments?
- Over 2 years (2023 to 2025), Achieve Life Sciences's contingent consideration fair value adjustments has grown at a -12.1% compound annual growth rate (CAGR), from $528K to $408K.